Gadofosveset-enhanced magnetic resonance imaging of human carotid atherosclerotic plaques: A proof-of-concept study

Investigative Radiology

Volumn 45, Issue 5, 2010, Pages 275-281

  Lobbes, Marc B I ^a   Heeneman, Sylvia ^a   Passos, Valeria Lima ^b   Welten, Rob ^c   Kwee, Robert M ^a   Van Der Geest, Rob J ^d   Wiethoff, Andrea J ^e   Caravan, Peter ^e   Misselwitz, Bernd ^f   Daemen, Mat J A P ^a   Van Engelshoven, Jos M A ^a   Leiner, Tim ^a   Kooi, Marianne E ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c Sittard Geleen Heerlen   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e Epix Pharmaceuticals   (United States)

^f BAYER PHARMA AG   (Germany)

Author keywords

Atherosclerosis; Carotid arteries; Contrast agents; Gadofosveset; Intravascular contrast agent; Magnetic resonance imaging

Indexed keywords

ALBUMIN; CONTRAST MEDIUM; GADOFOSVESET;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY; CAROTID ENDARTERECTOMY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; MACROPHAGE; MALE; MICROVASCULATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

EID: 77951132372     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181d5466b     Document Type: Article

References (32)

1. Rothwell PM, Eliasziw M, Gutnikov SA, et al; Carotid Endarterectomy Trialist's Collaboration. Analyses of pooled data from the randomised controlled trials of endarterectomy for symptomatic carotid stenosis. Lancet. 2003;361:107-116.
2. Lusis AJ. Atherosclerosis. Nature. 2000;407:233-241.
3. Cappendijk VC, Kessels AG, Heeneman S, et al. Comparison of lipid-rich necrotic core size in symptomatic and asymptomatic carotid atherosclerotic plaques: initial results. J Magn Reson Imaging. 2008;27:1356-1361.
4. Yuan C, Kerwin WS. MRI of atherosclerosis. J Magn Reson Imaging. 2004;19:710-719.
5. Kwee RM, Van Engelshoven JM, Mess WH, et al. Reproducibility of fibrous cap status assessment of carotid artery plaques by contrast-enhanced MRI. Stroke. 2009;40:3017-3021.
6. Kerwin W, Hooker A, Spilker M, et al. Quantitative magnetic resonance imaging analysis of neovasculature volume in carotid atherosclerotic plaque. Circulation. 2003;107:851-856.
7. Kerwin WS, O'Brien KD, Ferguson MS, et al. Inflammation in carotid atherosclerotic plaque: a dynamic contrast-enhanced MR imaging study. Radiology. 2006;241:459-468.
8. Kerwin WS, Oikawa M, Yuan C, et al. MR imaging of adventitial vasa vasorum in carotid atherosclerosis. Magn Reson Med. 2008;59:507-514.
9. Lin W, Abendschein DR, Haacke EM. Contrast-enhanced magnetic resonance angiography of carotid arterial wall in pigs. J Magn Reson Imaging. 1997;7:183-190. (Pubitemid 28365658)
10. Goyen M, Shamsi K, Schoenberg SO. Vasovist-enhanced MR angiography. Eur Radiol. 2006;16(suppl 2):B9-B14.
11. Huppertz A, Kroll H, Klessen C, et al. Biphasic blood pool contrast agent-enhanced whole body MR angiography for treatment planning in patients with significant arterial stenosis. Invest Radiol. 2009;44:422-432.
12. Klessen C, Hein PA, Huppertz A, et al. First-pass whole-body magnetic resonance angiography (MRA) using the blood-pool contrast medium gado-fosveset-trisodium: comparison to gadopentetate dimeglumine. Invest Radiol. 2007;42:659-664.
13. Michaely HJ, Attenberger AI, Dietrich O, et al. Feasibility of gadofosveset-enhanced steady-state magnetic resonance angiography of the peripheral vessels at 3 Tesla with Dixon fat saturation. Invest Radiol. 2008;43:635-641.
14. Prompona M, Cyran C, Nikolaou K, et al. Contrast-enhanced whole-heart MR coronary angiography at 3.0 T using the intravascular contrast agent gado-fosveset. Invest Radiol. 2009;44:369-374.
15. Lüdemann L, Nafz B, Elsner F, et al. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent. Invest Radiol. 2009;44:125-134.
16. Corot C, Violas X, Robert P, et al. Comparison of different types of blood pool agents (P792, MS325, USPIO) in a rabbit MR angiography-like protocol. Invest Radiol. 2003;38:311-319.
17. Caravan P, Cloutier NJ, Greenfield MT, et al. The interaction of MS-325 with human serum albumin and its effect on proton relaxation rates. J Am Chem Soc. 2002;124:3152-3162.
18. Lobbes MBI, Miserus RJ, Heeneman S, et al. Atherosclerosis: contrast-enhanced MR imaging of vessel wall in rabbit model: comparison of gado-fosveset and gadopentetate dimeglumine. Radiology. 2009;250:682-691.
19. Virmani R, Kolodgie FD, Burke AP, et al. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage. Arterioscler Thromb Vasc Biol. 2005;25:54-61.
20. Zhang Y, Cliff WJ, Schoefl GI, et al. Immunohistochemical study of intimal microvessels in coronary atherosclerosis. Am J Pathol. 1993;143:164-172.
21. Cina CS, Clase CM, Haynes RB. Carotid endarterectomy for symptomatic carotid stenosis. Cochrane Database Syst Rev. 2000:CD001081.
22. Teruel JL, Sabater J, Galeano C, et al. The Cockroft-Gault formula is better than the MDRD equation for estimating glomerular filtration rate in patients with advanced renal failure. Nefrologia. 2007;3:313-319.
23. Eldredge HB, Spiller M, Chasse JM, et al. Species dependence of plasma protein binding and relaxivity of the gadolinium-based MRI contrast agent MS-325. Invest Radiol. 2006;41:229-243.
24. Adame IM, Van der Geest RJ, Wasserman BA, et al. Automatic segmentation and plaque characterization in atherosclerotic carotid artery MR images. MAGMA. 2004;16:227-234.
25. Cappendijk VC, Cleutjens KB, Heeneman S, et al. In vivo detection of hemorrhage in human atherosclerotic plaques with magnetic resonance imaging. J Magn Reson Imaging. 2004;20:105-110.
26. Virmani R, Kolodgie FD, Burke AP, et al. Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arterioscler Thromb Vasc Biol. 2000;20:1262-1275.
27. Weidner N. Current pathologic methods for measuring intratumoral mi-crovessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat. 1995;36:169-180.
28. Nicholson JP, Wolmarans MR, Park GR. The role of albumin in critical illness. Br J Anaesth. 2000;85:599-610.
29. Londono I, Leclerc Y, Bendayan M. Ultrastructural localization of endogenous albumin in human aortic tissue by protein A-gold immunocytochemis- try. Am J Pathol. 1992;140:179-191.
30. Mofidi R, Powell TI, Crotty T, et al. Angiogenesis in carotid atherosclerotic lesions is associated with timing of ischemic neurological events and presence of computed tomographic cerebral infarction in the ipsilateral cerebral hemisphere. Ann Vasc Surg. 2008;22:266-272.
31. Dunmore BJ, McCarthy MJ, Naylor AR, et al. Carotid plaque instability and ischemic symptoms are linked to immaturity of microvessels within plaques. J Vasc Surg. 2007;45:155-159.
32. Sluimer JC, Kolodgie F, Bijnens AP, et al. Infrequent pericyte coverage and clear structural abnormalities in intraplaque microvessels in human coronary atherosclerotic plaques. J Am Coll Cardiol. 2009;53:1517-1527.